Envestnet Asset Management Inc. Raises Stock Position in Integral Ad Science Holding Corp. (NASDAQ:IAS)

Key Points

• Envestnet Asset Management significantly increased its stake in Integral Ad Science Holding Corp. by 165.6%, now owning a total of 84,471 shares worth approximately $681,000.
• Several institutional investors, including Vanguard Group and Wells Fargo, have also boosted their positions in Integral Ad Science, contributing to a total institutional ownership of 95.78%.
• Analyst ratings for Integral Ad Science show seven hold ratings and six buy ratings, with the stock currently having an average target price of $13.65.

Envestnet Asset Management Inc. raised its holdings in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 165.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 84,471 shares of the company's stock after buying an additional 52,664 shares during the period. Envestnet Asset Management Inc. owned about 0.05% of Integral Ad Science worth $681,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in IAS. KLP Kapitalforvaltning AS purchased a new stake in shares of Integral Ad Science during the fourth quarter worth about $257,000. Vanguard Group Inc. boosted its holdings in shares of Integral Ad Science by 2.3% during the fourth quarter. Vanguard Group Inc. now owns 9,048,546 shares of the company's stock worth $94,467,000 after purchasing an additional 205,562 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Integral Ad Science by 0.8% during the fourth quarter. Geode Capital Management LLC now owns 1,848,738 shares of the company's stock worth $19,305,000 after purchasing an additional 14,079 shares during the period. Wells Fargo & Company MN raised its stake in Integral Ad Science by 9.8% in the fourth quarter. Wells Fargo & Company MN now owns 85,089 shares of the company's stock worth $888,000 after buying an additional 7,587 shares in the last quarter. Finally, Invesco Ltd. raised its stake in Integral Ad Science by 16.7% in the fourth quarter. Invesco Ltd. now owns 50,544 shares of the company's stock worth $528,000 after buying an additional 7,229 shares in the last quarter. 95.78% of the stock is currently owned by hedge funds and other institutional investors.

Integral Ad Science Stock Up 0.2%

NASDAQ:IAS traded up $0.02 during mid-day trading on Wednesday, reaching $8.07. The company's stock had a trading volume of 560,248 shares, compared to its average volume of 1,023,066. The stock has a fifty day moving average of $8.19 and a 200-day moving average of $8.56. Integral Ad Science Holding Corp. has a 1 year low of $6.26 and a 1 year high of $13.62. The firm has a market capitalization of $1.33 billion, a PE ratio of 27.83, a price-to-earnings-growth ratio of 1.38 and a beta of 1.57. The company has a quick ratio of 4.01, a current ratio of 4.01 and a debt-to-equity ratio of 0.01.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last posted its earnings results on Monday, May 12th. The company reported $0.05 EPS for the quarter, beating analysts' consensus estimates of $0.03 by $0.02. The company had revenue of $134.07 million during the quarter, compared to analysts' expectations of $129.20 million. Integral Ad Science had a net margin of 8.56% and a return on equity of 4.74%. Equities research analysts forecast that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the stock. Raymond James Financial upped their target price on shares of Integral Ad Science from $11.00 to $13.00 and gave the stock an "outperform" rating in a research note on Tuesday, May 13th. Wall Street Zen cut Integral Ad Science from a "buy" rating to a "hold" rating in a research note on Saturday. Stifel Nicolaus boosted their price target on Integral Ad Science from $13.00 to $14.00 and gave the stock a "buy" rating in a research note on Tuesday, July 22nd. Morgan Stanley decreased their price target on Integral Ad Science from $13.50 to $12.50 and set an "equal weight" rating for the company in a research note on Thursday, April 17th. Finally, Barclays boosted their price target on Integral Ad Science from $7.00 to $9.00 and gave the stock an "equal weight" rating in a research note on Tuesday, May 13th. Seven investment analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to MarketBeat, Integral Ad Science presently has a consensus rating of "Hold" and a consensus target price of $13.65.

Insider Activity at Integral Ad Science

In other news, CEO Lisa Utzschneider sold 8,285 shares of the stock in a transaction dated Thursday, July 10th. The shares were sold at an average price of $8.29, for a total transaction of $68,682.65. Following the sale, the chief executive officer directly owned 371,031 shares of the company's stock, valued at $3,075,846.99. This represents a 2.18% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders sold a total of 25,151 shares of company stock valued at $209,075 in the last quarter. 2.00% of the stock is owned by corporate insiders.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.